MMSI Stock Falls -12% With A 10-day Losing Spree On Wells Fargo Downgrade
Merit Medical Systems (MMSI) – a manufacturer of single-use interventional and diagnostic medical products. – hit a 10-day losing streak, with cumulative losses over this period amounting to -12%. The company’s market cap has crashed by about $565 Mil over the last 10 days and currently stands at $4.1 Bil.
The stock has YTD (year-to-date) return of 20.9% compared to -0.9% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Wells Fargo Downgrade
- What Is Driving Biogen’s Recent Drop and What Comes Next
- Does Caterpillar Stock Still Have Room to Run?
- Cash Machine Trading Cheap – Centene Stock Set to Run?
- Can a $25B Investment Surge Sustain Micron’s 20% AI Memory Grab?
- The Hidden Dangers Facing Apple Stock
- How to Get Paid to Buy PYPL at a Steep Discount
- Rating cut to ‘Equal Weight’ from ‘Overweight’
- Price target slashed to $78 from $95
- Impact: Sharp Reversal in Investor Sentiment, Sustained Institutional Selling
Opportunity or Trap?
Below is our take on valuation.
There is not much to fear in MMSI stock given its overall Strong operating performance and financial condition. Considering stock’s Moderate valuation, we think it is Attractive (For details, see Buy or Sell MMSI).
But here is the real interesting point.
You are reading about this -12% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for MMSI stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | MMSI | S&P 500 |
|---|---|---|
| 1D | -3.0% | -0.2% |
| 10D (Current Streak) | -15.4% | -1.6% |
| 1M (21D) | -15.5% | -2.2% |
| 3M (63D) | -16.4% | -1.3% |
| YTD 2026 | -20.9% | -0.9% |
| 2025 | -8.9% | 16.4% |
| 2024 | 27.3% | 23.3% |
| 2023 | 7.6% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: MMSI Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 10 S&P constituents with 3 days or more of consecutive gains and 101 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 6 | 37 |
| 4D | 0 | 31 |
| 5D | 2 | 5 |
| 6D | 0 | 9 |
| 7D or more | 2 | 19 |
| Total >=3 D | 10 | 101 |
Key Financials for Merit Medical Systems (MMSI)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $1.4 Bil | $1.5 Bil |
| Operating Income | $156.1 Mil | $185.7 Mil |
| Net Income | $120.4 Mil | $128.5 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ3 | 2025 FQ4 |
|---|---|---|
| Revenues | $384.2 Mil | $393.9 Mil |
| Operating Income | $42.6 Mil | $54.0 Mil |
| Net Income | $27.8 Mil | $38.0 Mil |
The losing streak MMSI stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.